Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Diagnosis as a Strategy in Reducing the Incidence of Acute Renal Failure and Mortality Associated With Contrast Media Administration in Cardiovascular Procedures

NCT04225013 is registered in ClinicalTrials.gov with R. Laura Vicente Vicente as lead sponsor.

NCT NCT04225013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04225013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Diagnosis as a Strategy in Reducing the Incidence of Acute Renal Failure and Mortality Associated With Contrast Media Administration in Cardiovascular Procedures
Lead sponsor
R. Laura Vicente Vicente
Phase
Observational
Overall status
Completed
Start date
June 1, 2015
Completion date
June 1, 2018
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast-induced nephropathy, kidney injury